Transforming Oncology
Advancing GBM treatment through pioneering research and transformative therapies for improved patient outcomes.
CNS Pharmaceuticals Recently Announced it has Expanded its Pipeline with In-License of Late Stage, Novel Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
Company Hosted Webcast July 30th
Our Focus
Our primary focus is on glioma, specifically glioblastoma multiforme (GBM), an aggressive and currently incurable form of brain cancer. With a deep understanding of the disease and a commitment to innovation, we aim to change the prognosis for patients suffering from this devastating condition. Discover more about glioblastoma multiforme and our approach to tackling it.
Learn More about Our FocusFor Patients
CNS Pharmaceuticals is dedicated to supporting patients and their families throughout their cancer journey. Our 'For Patients' page offers valuable resources, including information about our clinical trials, treatment options, and support networks. Visit our 'For Patients' page to learn more and find the help you need.
Learn More about For PatientsOur Pipeline
Our primary focus is on glioblastoma multiforme, an aggressive and currently incurable form of brain cancer. With a deep understanding of the disease and a commitment to innovation, we aim to change the prognosis for patients suffering from this devastating condition. Discover more about glioblastoma multiforme and our approach to tackling it.
Learn More about Our PipelineLatest News
CNS Pharmaceuticals Reports Full Year 2024 Financial Results
Read More of CNS Pharmaceuticals Reports Full Year 2024 Financial ResultsCNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
Read More of CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma MultiformeCNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
Read More of CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ ListingInvestor Relations
Explore our financial data and market performance. Get a clear picture of our strategic outlook.
Presentations
Access our comprehensive publications and presentations page for information on our research programs.
Email Alerts
Get timely updates on our latest developments. Subscribe to email alerts for new press releases, events, and filings.
Pipeline
Track our ongoing research and development projects. Monitor the progress and future of our drug programs.